AVITA Medical (AVHHL) Return on Capital Employed (2019 - 2025)

AVITA Medical has reported Return on Capital Employed for 7 years, with the latest figure at 1625.37% in Q4 2025.

• For the quarter ending Q4 2025, Return on Capital Employed rose 164692.0% year-over-year to 1625.37%; the trailing twelve-month figure through Dec 2025 stood at 1625.37% (up 164692.0% YoY), and the FY2025 full-year result was 791.4%, down 77422.0% from the prior year.
• Return on Capital Employed for Q4 2025 stood at 1625.37%, up from 170.22% in the prior quarter.
• The five-year high for Return on Capital Employed was 1625.37% in Q4 2025, with the low at 251.09% in Q2 2025.
• Historically, Return on Capital Employed has averaged 40.13% across 5 years, with a median of 23.59% in 2021.
• The largest YoY upside for Return on Capital Employed was 164692 bps in 2025 against a maximum downside of 18205 bps in 2025.
• AVITA Medical's Return on Capital Employed stood at 19.16% in 2021, then jumped by 69 bps to 5.86% in 2022, then sank by 776 bps to 51.31% in 2023, then soared by 58 bps to 21.55% in 2024, then soared by 7644 bps to 1625.37% in 2025.
• The last three Return on Capital Employed figures came in at 1625.37% (Q4 2025), 170.22% (Q3 2025), and 251.09% (Q2 2025), per Business Quant data.